Impact of erythropoietin on intensive care unit patients
about
Model for end-stage liver disease (MELD) score as a predictor and monitor of mortality in patients with Vibrio vulnificus necrotizing skin and soft tissue infectionsHematopoietic Growth Factors in Transfusion Medicine and Cellular Therapy - Part II.Characterization of erythropoietin and hepcidin in the regulation of persistent injury-associated anemia.Cytokines, granulocyte-monocyte colony stimulating factor, interleukin-3 and erythropoietin: Can be a therapeutic option for the stimulation of hematopoietic progenitor cells in trauma-hemorrhagic shock?Low-dose erythropoietin treatment is not associated with clinical benefits in severely anaemic Jehovah's Witnesses: a plea for a change.Discrete β-adrenergic mechanisms regulate early and late erythropoiesis in erythropoietin-resistant anemia.
P2860
Impact of erythropoietin on intensive care unit patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of erythropoietin on intensive care unit patients
@en
Impact of erythropoietin on intensive care unit patients.
@nl
type
label
Impact of erythropoietin on intensive care unit patients
@en
Impact of erythropoietin on intensive care unit patients.
@nl
prefLabel
Impact of erythropoietin on intensive care unit patients
@en
Impact of erythropoietin on intensive care unit patients.
@nl
P2860
P356
P1476
Impact of erythropoietin on intensive care unit patients
@en
P2093
Ines Jelkmann
Wolfgang Jelkmann
P2860
P304
P356
10.1159/000354128
P577
2013-08-16T00:00:00Z